Close Menu

Danaher

News items for the in vitro diagnostics industry for the week of March 29, 2021.

Danaher’s guidance of double-digit top-line growth for 2021 provides upside opportunities that depend mostly on the success of vaccine rollouts, Barclays said.

News items for the in vitro diagnostics industry for the week of Feb. 22, 2021.

The company's life sciences revenues grew 76 percent, while diagnostics revenues increased 24 percent.

Exact Sciences discussed newly released data and its plans for Cologuard, while Luminex provided details about its warning letter from the FDA.

Some insiders emphasize the importance of doing rapid turnaround testing of asymptomatic people, while others contend lab tests ought to be the modality of choice.

The company's goal is to help laboratories and smaller diagnostic firms accelerate test development and provide end-to-end test design assistance.

The revenue increase was driven by significant growth in the conglomerate's life sciences segment.

News items for the in vitro diagnostics industry for the week of Oct. 5, 2020

Pages